GHTF (Global Harmonization Task Force) organises 2005 meetings schedule:
This article was originally published in Clinica
The Global Harmonization Task Force has posted its 2005 meetings as follows: Study Group 5 (clinical investigations) on January 17-19 in Canberra, Australia; SG 1 (regulatory requirements/premarket review) will meet in Switzerland between February 21-24; and SG 3 (quality system requirements) in Paris between February 31 and March 2. There then follows a meeting of SG 2 (vigilance/post-market surveillance) in Sydney from March 1-3. For further information about meetings from April onwards, and including meetings of SG 4 (auditing) visit the GHTF website at: www.ghtf.org
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.
The introduction of gene therapies has been the highest-profile new modality to reach the market, but new RNA-based therapeutics hold significant potential and could be more accessible for patients. Scrip reviews the leading drug developers in this space.